Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells
Xiaoxin Shi, Amir Valizadeh, Seyed Mostafa Mir, et al.
European Journal of Pharmacology (2020) Vol. 880, pp. 173138-173138
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 132
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Roberto Mattioli, Andrea Ilari, Beatrice Colotti, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101205-101205
Open Access | Times Cited: 118
The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer
Yu Wang, Yingying Wang, Zhiyuan Qin, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 3, pp. 291-306
Closed Access | Times Cited: 110
Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review)
Yichen Tian, Yongrong Lei, Yani Wang, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 5
Open Access | Times Cited: 50
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20
hPMSCs-Derived Exosomal miRNA-21 Protects Against Aging-Related Oxidative Damage of CD4+ T Cells by Targeting the PTEN/PI3K-Nrf2 Axis
Yanlian Xiong, Yanlei Xiong, Hengchao Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
Find new channel for overcoming chemoresistance in cancers: Role of stem cells-derived exosomal microRNAs
Ghufran Mohammed Hussein, Shaimaa M. Mohammed, Mohammed Faris, et al.
International Journal of Biological Macromolecules (2022) Vol. 219, pp. 530-537
Closed Access | Times Cited: 28
lncRNAs: New players of cancer drug resistance via targeting ABC transporters
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 6
The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets
Sepideh Mirzaei, Asal Jalal Abadi, Mohammad Gholami, et al.
European Journal of Pharmacology (2021) Vol. 908, pp. 174344-174344
Closed Access | Times Cited: 35
MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer
Wenyan Mo, Shi-Qiong Cao
Clinical & Translational Oncology (2022) Vol. 25, Iss. 3, pp. 563-577
Open Access | Times Cited: 23
Mesenchymal Stem Cell-derived Extracellular Vesicles Transmitting MicroRNA-34a-5p Suppress Tumorigenesis of Colorectal Cancer Through c-MYC/DNMT3a/PTEN Axis
Jiangning Zhao, Huanrong Lin, Kunsong Huang
Molecular Neurobiology (2021) Vol. 59, Iss. 1, pp. 47-60
Open Access | Times Cited: 30
miR‐21 inhibition reverses doxorubicin‐resistance and inhibits PC3 human prostate cancer cells proliferation
Weichong Zhao, Lei Ning, Lihui Wang, et al.
Andrologia (2021) Vol. 53, Iss. 5
Open Access | Times Cited: 29
Early stress exposure on zebrafish development: effects on survival, malformations and molecular alterations
David G. Valcarce, Alba Sellés-Egea, Marta F. Riesco, et al.
Fish Physiology and Biochemistry (2024) Vol. 50, Iss. 4, pp. 1545-1562
Open Access | Times Cited: 4
MiRNAs: main players of cancer drug resistance target ABC transporters
Forogh Mohammadi, Masoumeh Nejatollahi, Farhad Sheikhnia, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Nanoscale strategies: doxorubicin resistance challenges and enhancing cancer therapy with advanced nanotechnological approaches
Jian Xin Lim, Yoke Keong Yong, Firli Rahmah Primula Dewi, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance
Di Wu, Chunjie Huang, Kaifeng Guan
Biochemical Pharmacology (2024) Vol. 226, pp. 116406-116406
Closed Access | Times Cited: 3
Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view
Fatemeh Ebadi Meinag, Mina Fatahi, Vahid Vahedian, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 3
miR-29a-3p directly targets Smad nuclear interacting protein 1 and inhibits the migration and proliferation of cervical cancer HeLa cells
Ying Chen, Weiji Zhang, Lijun Yan, et al.
PeerJ (2020) Vol. 8, pp. e10148-e10148
Open Access | Times Cited: 25
The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer
Isaac Micallef, Byron Baron
Non-Coding RNA (2021) Vol. 7, Iss. 2, pp. 24-24
Open Access | Times Cited: 23
Exposure to High-Altitude Environment Is Associated with Drug Transporters Change: microRNA-873-5p-Mediated Alteration of Function and Expression Levels of Drug Transporters under Hypoxia
Yabin Duan, Xue Bai, Jianxin Yang, et al.
Drug Metabolism and Disposition (2021) Vol. 50, Iss. 2, pp. 174-186
Open Access | Times Cited: 19
Protective Role of lncRNA TTN-AS1 in Sepsis-Induced Myocardial Injury Via miR-29a/E2F2 Axis
Xinghua Pei, Yanhong Wu, Haiming Yu, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 36, Iss. 3, pp. 399-412
Closed Access | Times Cited: 18
Hyaluronic Acid-Modified Nanoparticles Self-Assembled from Linoleic Acid-Conjugated Chitosan for the Codelivery of miR34a and Doxorubicin in Resistant Breast Cancer
Xiaoxia Yang, Pengfei Shang, Jianbo Ji, et al.
Molecular Pharmaceutics (2021) Vol. 19, Iss. 1, pp. 2-17
Closed Access | Times Cited: 18
Emerging Roles of Long Non-Coding RNAs in Ankylosing Spondylitis
Ruifu Sun, Xuesong Wang, Xiaohong Sun, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Cancer drug resistance related microRNAs: recent advances in detection methods
Xinyuan Hu, Zhen Song, Zi-Wei Yang, et al.
The Analyst (2022) Vol. 147, Iss. 12, pp. 2615-2632
Closed Access | Times Cited: 11
Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications
Matthew Moghaddam, Silvia Vivarelli, Luca Falzone, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 170-207
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top